Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Proteases in MHC class I presentation and cross-presentation.

Rock KL, Farfán-Arribas DJ, Shen L.

J Immunol. 2010 Jan 1;184(1):9-15. doi: 10.4049/jimmunol.0903399. Review.

2.

Cross-priming.

Bevan MJ.

Nat Immunol. 2006 Apr;7(4):363-5. Review. No abstract available.

PMID:
16550200
3.

Cross-presentation: underlying mechanisms and role in immune surveillance.

Rock KL, Shen L.

Immunol Rev. 2005 Oct;207:166-83. Review.

PMID:
16181335
4.

Priming of T cells by exogenous antigen cross-presented on MHC class I molecules.

Shen L, Rock KL.

Curr Opin Immunol. 2006 Feb;18(1):85-91. Epub 2005 Dec 2. Review.

PMID:
16326087
5.

The cross-priming pathway: a portrait of an intricate immune system.

Basta S, Alatery A.

Scand J Immunol. 2007 Apr;65(4):311-9. Review.

6.

Mechanisms of MHC class I-restricted antigen processing and cross-presentation.

Cresswell P, Ackerman AL, Giodini A, Peaper DR, Wearsch PA.

Immunol Rev. 2005 Oct;207:145-57. Review.

PMID:
16181333
7.

Cross-dressing: an alternative mechanism for antigen presentation.

Campana S, De Pasquale C, Carrega P, Ferlazzo G, Bonaccorsi I.

Immunol Lett. 2015 Dec;168(2):349-54. doi: 10.1016/j.imlet.2015.11.002. Epub 2015 Nov 10. Review.

PMID:
26551033
8.

A modular and combinatorial view of the antigen cross-presentation pathway in dendritic cells.

Segura E, Villadangos JA.

Traffic. 2011 Dec;12(12):1677-85. doi: 10.1111/j.1600-0854.2011.01254.x. Epub 2011 Aug 16. Review.

9.

Cross-presentation of peptides from intracellular pathogens by MHC class I molecules.

Blanchard N, Shastri N.

Ann N Y Acad Sci. 2010 Jan;1183:237-50. doi: 10.1111/j.1749-6632.2009.05135.x. Review.

PMID:
20146719
10.

The impact of macroautophagy on CD8(+) T-cell-mediated antiviral immunity.

Perot BP, Ingersoll MA, Albert ML.

Immunol Rev. 2013 Sep;255(1):40-56. doi: 10.1111/imr.12096. Review.

PMID:
23947346
11.

Generation of MHC class I ligands in the secretory and vesicular pathways.

Del Val M, Iborra S, Ramos M, Lázaro S.

Cell Mol Life Sci. 2011 May;68(9):1543-52. doi: 10.1007/s00018-011-0661-2. Epub 2011 Mar 9. Review.

PMID:
21387141
12.

Heat shock proteins in antigen trafficking--implications on antigen presentation to T cells.

Udono H, Ichiyanagi T, Mizukami S, Imai T.

Int J Hyperthermia. 2009 Dec;25(8):617-25. doi: 10.3109/02656730902902183. Review.

PMID:
19551545
13.

Dying cells actively regulate adaptive immune responses.

Yatim N, Cullen S, Albert ML.

Nat Rev Immunol. 2017 Apr;17(4):262-275. doi: 10.1038/nri.2017.9. Epub 2017 Mar 13. Review.

PMID:
28287107
14.

Toward a molecular explanation for cross-presentation of antigens to the immune system.

Khor B, Makar RS.

Transfus Med Rev. 2008 Jul;22(3):188-201. doi: 10.1016/j.tmrv.2008.02.002. Review.

PMID:
18572095
15.

CD8+ T-cell priming regulated by cytokines of the innate immune system.

Stäger S, Kaye PM.

Trends Mol Med. 2004 Aug;10(8):366-71. Review.

PMID:
15310456
16.

Not all effector CD8+ T cells are alike.

Drake DR 3rd, Braciale TJ.

Microbes Infect. 2003 Mar;5(3):199-204. Review.

PMID:
12681408
17.

Designing CD8+ T cell vaccines: it's not rocket science (yet).

Yewdell JW.

Curr Opin Immunol. 2010 Jun;22(3):402-10. doi: 10.1016/j.coi.2010.04.002. Epub 2010 May 4. Review.

18.

Defining cross presentation for a wider audience.

Norbury CC.

Curr Opin Immunol. 2016 Jun;40:110-6. doi: 10.1016/j.coi.2016.04.003. Epub 2016 Apr 18. Review.

PMID:
27101579
19.

Re-examining class-I presentation and the DRiP hypothesis.

Rock KL, Farfán-Arribas DJ, Colbert JD, Goldberg AL.

Trends Immunol. 2014 Apr;35(4):144-52. doi: 10.1016/j.it.2014.01.002. Epub 2014 Feb 21. Review.

20.

[Heat shock protein and antigen cross-presentation].

Udono H.

Seikagaku. 2012 Oct;84(10):829-39. Review. Japanese. No abstract available.

PMID:
23240536

Supplemental Content

Support Center